Also on Trial Friend:Primary Central Nervous System Lymphoma pageMatch Me
All 61 Primary Central Nervous System Lymphoma trials and their US sites
Enter your ZIP code above to sort them by how far their nearest open site is from you.
- DALY II USA/ MB-CART2019.1 for DLBCLMost sites in Texas, Arizona and CaliforniaRecruitingPhase 2Ages 18+Miltenyi Biomedicine28US sites
23 states - IGNITE: Study of Tirabrutinib vs Rituximab and Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)Most sites in New York, Massachusetts and PennsylvaniaRecruitingPhase 3Ages 18+Ono Pharmaceutical Co.27US sites
15 states - CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)Most sites in New York, California and ArizonaRecruitingPhase 1/2Ages 18+Curis18US sites
15 states - A Study of NX-5948 in Adults With Relapsed/Refractory B-cell MalignanciesMost sites in California, Florida and OhioRecruitingPhase 1Ages 18+Nurix Therapeutics15US sites
12 states - Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFUMost sites in Arizona, California and ConnecticutRecruitingAges 18+Miltenyi Biomedicine11US sites
11 states - A Study of Epcoritamab and Ibrutinib in People With Central Nervous System Lymphoma (CNSL)Most sites in New York, New Jersey and UtahRecruitingPhase 1Ages 18+Memorial Sloan Kettering Cancer Center8US sites
3 states - A Study of MB-CART19.1 Cellular Therapy for People With Central Nervous System Lymphoma (CNSL)Most sites in New York and New JerseyRecruitingPhase 1Ages 18+Memorial Sloan Kettering Cancer Center7US sites
2 states - A Study of NX-2127 in Adults With Relapsed/Refractory B-cell MalignanciesMost sites in California, Colorado and IllinoisRecruitingPhase 1Ages 18+Nurix Therapeutics7US sites
7 states - Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial ResponseMost sites in New York, Oregon and PennsylvaniaRecruitingPhase 2Ages 18+Providence Health & Services6US sites
6 states - T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)Most sites in California, Ohio and OregonRecruitingPhase 1/2Ages 18+Estrella Immunopharma5US sites
5 states - Loncastuximab Tesirine and Rituximab Following Stereotactic Radiosurgery in Patients With Central Nervous System Lymphomas (SOLAR)Most sites in Pennsylvania, Rhode Island and UtahRecruitingPhase 1Ages 18+University of Utah3US sites
3 states - Pembrolizumab, Ibrutinib and Rituximab in PCNSLMost sites in Massachusetts and New YorkRecruitingPhase 1/2Ages 18+Dana-Farber Cancer Institute3US sites
2 states - Paxalisib (GDC-0084) In Recurrent Or Refractory PCNSLOnly in MassachusettsRecruitingPhase 2Ages 18+Lakshmi Nayak, MD2US sites
- Pembrolizumab + Chemotherapy in Newly Diagnosed PCNSLOnly in MassachusettsRecruitingPhase 1Ages 18+Dana-Farber Cancer Institute2US sites
- Q702 for the Treatment of Patients With Hematologic MalignanciesMost sites in Arizona and MinnesotaRecruitingPhase 1Ages 18+Mayo Clinic2US sites
2 states - CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell MalignanciesOnly in WisconsinRecruitingPhase 1/2Ages 18-80Medical College of Wisconsin1US site
- Feasibility of Acquiring Hyperpolarized Imaging in Patients With Primary CNS LymphomaOnly in CaliforniaRecruitingPhase 1Ages 18+James Rubenstein1US site
- Glofitamab With Obinutuzumab Pre-treatment for the Treatment of Central Nervous System LymphomaOnly in CaliforniaRecruitingPhase 1Ages 18+City of Hope Medical Center1US site
- Intracerebroventricular Administration of CD19-CAR T Cells (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/Mem T-lymphocytes) for the Treatment of Central Nervous System LymphomaOnly in CaliforniaRecruitingPhase 1Ages 18+City of Hope Medical Center1US site
- Long-term Follow-up Study of Patients Receiving CAR-T CellsOnly in WisconsinRecruitingAges 18-80Medical College of Wisconsin1US site
New trials, status changes and new sites, straight from ClinicalTrials.gov. Unsubscribe anytime.
- Trial Alerts, when a new trial opens or a trial changes
- Disease Updates, FDA decisions and condition news, usually 1 or 2 emails a month
Who runs the Primary Central Nervous System Lymphoma trials in the US, and what stage they are in
Of the 25 Primary Central Nervous System Lymphoma trials with a US site, 1 is in Phase 3, the last stage before a company can ask the FDA for approval. Earlier Phase 1 or 2 tests of safety and dosing make up 20 of them. The remaining 4 have no drug phase, such as studies that follow people over time or test a device or a way of giving care. Companies run 7 of them, and universities, hospitals, foundations and government groups run 18. The sponsors with the most are Dana-Farber Cancer Institute (3), City of Hope Medical Center (2) and James Rubenstein (2). The most recently listed one first appeared on ClinicalTrials.gov on July 17, 2026.
Primary Central Nervous System Lymphoma trials in the US, state by state
None of the 25 Primary Central Nervous System Lymphoma trials with a US site lists children under 18 as eligible. A trial counts once in each state where it has an open site, and some trials accept both children and adults.
Show the other 20 states
US hospitals running the most Primary Central Nervous System Lymphoma trials
Centers that run trials for a rare condition often see more people with it than most clinics do, so this list can also help you find doctors who know Primary Central Nervous System Lymphoma.
- Dana Farber Cancer InstituteBoston, Massachusetts6 trials
- Memorial Sloan Kettering Cancer CenterNew York, New York5 trials
- City of HopeDuarte, California3 trials
- University of California, San FranciscoSan Francisco, California3 trials
- Banner MD Anderson Cancer CenterGilbert, Arizona2 trials
- Beth Israel Deaconess Medical CenterBoston, Massachusetts2 trials
- Brigham and Women's HospitalBoston, Massachusetts2 trials
- City of Hope Medical CenterDuarte, California2 trials
- Cleveland ClinicCleveland, Ohio2 trials
- Colorado Blood Cancer InstituteDenver, Colorado2 trials
Help getting to a Primary Central Nervous System Lymphoma trial far from home
Ask the study team whether the trial pays back travel, parking and hotel costs, because many sponsors do. The FDA's guidance on paying research volunteers says paying back these costs does not count as pressuring someone to join.
These nonprofits also help patients reach care, and each one sets its own rules.
- Mercy Medical Angels
- Pays for gas cards, ground rides and airline tickets anywhere in the US, and it lists clinical trials as a reason to travel. Household income at or below 300% of the federal poverty guidelines, and usually a trip of 50 miles or more each way.
- Air Charity Network
- Volunteer pilots in all 50 states fly patients for free in small private planes, and members also fly people taking part in clinical trials. You must be able to walk and sit upright for the flight, show financial need and have a backup plan if weather cancels it.
- Corporate Angel Network
- Puts cancer patients in empty seats on business jets for treatment, second opinions and clinical trials. Open to anyone with cancer who can walk and travel without medical help, and it does not check income.
- American Cancer Society Hope Lodge
- Offers a free place to stay at 31 Hope Lodge locations for people getting cancer treatment far from home. People facing cancer and their caregivers, when treatment is far from home.
- Healthcare Hospitality Network
- Keeps a map of hospitality houses near hospitals, and most member houses charge little or nothing to patients and families. Each house sets its own rules, so check with the house near your study site.
Program details were checked on each program's website on October 24, 2026.
Questions about finding a Primary Central Nervous System Lymphoma trial near you
Are there Primary Central Nervous System Lymphoma clinical trials near me?
As of November 21, 2026, 61 Primary Central Nervous System Lymphoma clinical trials are recruiting now and 9 are not yet recruiting. In the US, 25 of them have at least 1 open site, across 29 states and Washington, DC. Enter your ZIP code on this page to rank every one of them by the distance to its closest open site, with the sites shown on a map.
Which states have Primary Central Nervous System Lymphoma clinical trial sites?
Recruiting Primary Central Nervous System Lymphoma trials list open sites in 29 states and Washington, DC. California, Massachusetts and New York have the most, and the table on this page lists every state.
Are there Primary Central Nervous System Lymphoma trials for children near me?
None of the 25 Primary Central Nervous System Lymphoma trials with a US site lists children under 18 as eligible. Each trial sets its own age limits, so check the ages listed on a trial before you contact it.
Who pays for travel to a Primary Central Nervous System Lymphoma clinical trial?
Many trial sponsors pay back travel, parking and hotel costs, so ask the study team before you rule out a far-away site. The FDA's guidance says paying back these costs does not count as pressuring someone to join. Charities such as Mercy Medical Angels and Air Charity Network can also help with rides and flights, and Corporate Angel Network flies cancer patients for free.
What if there is no Primary Central Nervous System Lymphoma trial near me?
Some trials send staff to your home or use a local lab, so fewer visits happen at the study site. You can also sign up on this page to get an email when a Primary Central Nervous System Lymphoma trial opens a new site or changes status.
How is the distance to a trial site measured?
Distances are straight-line miles from the center of your ZIP code to each study site's listed location, not driving distance. Your browser looks up the ZIP code's coordinates with a free map service, Zippopotam.us, and the ZIP code is never sent to or stored by Trial Friend.
Clinical trials near you for related conditions
Source: ClinicalTrials.gov, trials with status Recruiting or Not yet recruiting. Refreshed every 6 hours; counts as of November 21, 2026. Sites that ClinicalTrials.gov lists as closed or withdrawn are left out. Children means the trial's age group includes people under 18.
